# Safety and Performance Study of the MitralStitch Repair System.

Study · id `cardio:ct-nct04080362` · Cardiovascular Atlas · release `a25293eeae6350fb` (public)

> General information from published sources, not medical advice, and not reviewed by clinicians. Check the cited source before relying on anything here. Sponsors do not influence what this atlas says.

The atlas's own text and curation may be reused under Creative Commons Attribution-NonCommercial 4.0 International (CC BY-NC 4.0, https://creativecommons.org/licenses/by-nc/4.0/): credit the atlas, and do not use it commercially without a licence from the owner. See the atlas About page. Text quoted from a source stays under that source's own terms, given as the source's reuse\_basis. The atlas's reuse terms do not cover it. The downloads list each quotation with its source in third\_party\_quotations.

**Registry record.** Assembled by a program from [ClinicalTrials.gov record NCT04080362](<https://clinicaltrials.gov/study/NCT04080362>), retrieved 26 October 2026. No person wrote or checked this page.

Also called: NCT04080362

Browse, organ or system: Heart  
Browse, condition area: Heart failure; Valve and congenital heart disease  

## In plain language

A trial with no phase registered on ClinicalTrials.gov. The registry status is unknown. It plans to enroll 150 participants.

## Technical summary

Registry record NCT04080362. Allocation not applicable; no masking; primary purpose treatment. Start 2019-07-05 (actual); primary completion 2021-06-01 (anticipated). Results not posted.

## Key facts

- Design: Interventional study; allocation not applicable; no masking; primary purpose treatment
- Phase: Not applicable
- Enrolled: 150 participants (planned count; ClinicalTrials.gov record NCT04080362, source copy `cardio:ctgov-nct04080362-2020-02-28`, retrieved 2026-10-26)
- Started: 2019-07-05 (actual) (ClinicalTrials.gov record NCT04080362, source copy `cardio:ctgov-nct04080362-2020-02-28`, retrieved 2026-10-26)
- Primary completion: 2021-06-01 (anticipated) (ClinicalTrials.gov record NCT04080362, source copy `cardio:ctgov-nct04080362-2020-02-28`, retrieved 2026-10-26)
- Completion: 2022-06-01 (anticipated) (ClinicalTrials.gov record NCT04080362, source copy `cardio:ctgov-nct04080362-2020-02-28`, retrieved 2026-10-26)
- Countries: China (ClinicalTrials.gov record NCT04080362, source copy `cardio:ctgov-nct04080362-2020-02-28`, retrieved 2026-10-26)
- Care setting: Not reported
- Registry status: "UNKNOWN" (U.S. National Library of Medicine (ClinicalTrials.gov), source copy `cardio:ctgov-nct04080362-2020-02-28`, retrieved 2026-10-26)

## The registry's words

- Brief title: Safety and Performance Study of the MitralStitch Repair System.
- Condition: Mitral Regurgitation
- Intervention (Device): MitralStitch
- Lead sponsor: Hangzhou Valgen Medtech Co., Ltd
- Lead sponsor class: INDUSTRY

## Connected pages

- Registry condition terms include this condition: Heart valve disease (`cardio:heart-valve-disease`)
- Registry condition terms include this condition: Mitral regurgitation (`cardio:mitral-regurgitation`)
- Registry lists this organization as the lead sponsor: Hangzhou Valgen Medtech Co., Ltd (`cardio:org-hangzhou-valgen-medtech-co-ltd`)

## Provenance

Content hash: 57ae78602d500ffafbdb586d38759eb571370a53b9f4df2720fdbb3a001cd0b3
Last substantive edit: 2026-11-08
Evidence last checked: Not recorded
